Skip to Content
Merck
All Photos(1)

Key Documents

View All Documentation

Safety Information

O3750

Sigma-Aldrich

Oxamic acid

≥98%

Synonym(s):

Aminooxoacetic acid, Oxalic acid monoamide

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Linear Formula:
NH2COCO2H
CAS Number:
471-47-6
Molecular Weight:
89.05
Beilstein:
1743294
EC Number:
207-443-0
MDL number:
MFCD00008006
UNSPSC Code:
12352100
PubChem Substance ID:
57654482
NACRES:
NA.22

Quality Level

100

Assay

≥98%

form

powder

mp

207-210 °C (dec.) (lit.)

SMILES string

NC(=O)C(O)=O

InChI

1S/C2H3NO3/c3-1(4)2(5)6/h(H2,3,4)(H,5,6)

InChI key

SOWBFZRMHSNYGE-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Application

Oxamic acid (OA) can be used as a reactant to prepare 6-phenanthridinecarboxamide by direct C-H carbamoylation reaction using ammonium persulfate in DMSO. It can also be used as an organic ligand to prepare functionalized metal oxide nanoparticles for various biological applications. OA along with p-aminobenzoic acid is used to functionalize Au nanoparticles for the development of a sensor to detect Fe3+ ions by the calorimetric method.

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Regulatory Listings

Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.

JAN Code

O3750-5G:
O3750-10G:
O3750-1G:
O3750-VAR:
O3750-BULK:
O3750-25G:

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
STBK4201
STBJ6221
STBJ3839
STBH7544
STBH7154

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Chrysi Xintaropoulou et al.
BMC cancer, 18(1), 636-636 (2018-06-06)
Novel therapeutic approaches are required to treat ovarian cancer and dependency on glycolysis may provide new targets for treatment. This study sought to investigate the variation of expression of molecular components (GLUT1, HKII, PKM2, LDHA) of the glycolytic pathway in
Adam D Moorhouse et al.
Chemical communications (Cambridge, England), 47(1), 230-232 (2010-08-03)
hLDH-5 has emerged as a promising target for anti-glycolytic cancer chemotherapy. Here we report a first generation of bifunctional inhibitors, which show promising activity against hLDH-5.
Richard A Ward et al.
Journal of medicinal chemistry, 55(7), 3285-3306 (2012-03-16)
Lactate dehydrogenase A (LDHA) catalyzes the conversion of pyruvate to lactate, utilizing NADH as a cofactor. It has been identified as a potential therapeutic target in the area of cancer metabolism. In this manuscript we report our progress using fragment-based
Metal-, Photocatalyst-, and Light-Free Direct C-H Acylation and Carbamoylation of Heterocycles
Westwood MT, et al.
Organic Letters, 21(17), 7119-7123 (2019)
Xuguang Yang et al.
Cancer immunology research, 8(11), 1440-1451 (2020-09-13)
The mechanisms responsible for radioresistance in pancreatic cancer have yet to be elucidated, and the suppressive tumor immune microenvironment must be considered. We investigated whether the radiotherapy-augmented Warburg effect helped myeloid cells acquire an immunosuppressive phenotype, resulting in limited treatment
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service